Cancer BiologybioRxiv
Oncogenic role of sFRP2 in P53-mutant osteosarcoma development via autocrine and paracrine mechanism
H. S. Kim, S. Yoo, J. M. Bernitz…·C. Schaniel
This study identifies sFRP2 as an oncogenic driver in P53-mutant osteosarcoma through autocrine and paracrine mechanisms, showing its role in promoting tumor growth and poor survival.
DOI 10.1073/pnas.1814044115